152 related articles for article (PubMed ID: 22335963)
1. Molecular study and genotype/phenotype correlation of β Thalassemia in Malaysia.
Sivalingam M; Looi ML; Zakaria SZ; Hamidah NH; Alias H; Latiff ZA; Ibrahim H; Jamal R
Int J Lab Hematol; 2012 Aug; 34(4):377-82. PubMed ID: 22335963
[TBL] [Abstract][Full Text] [Related]
2. A Large Cohort Study of Genotype and Phenotype Correlations of Beta- Thalassemia in Iranian Population.
Maryami F; Azarkeivan A; Fallah MS; Zeinali S
Int J Hematol Oncol Stem Cell Res; 2015 Oct; 9(4):198-202. PubMed ID: 26865931
[TBL] [Abstract][Full Text] [Related]
3. The molecular characterization of Beta globin gene in thalassemia patients reveals rare and a novel mutations in Pakistani population.
Yasmeen H; Toma S; Killeen N; Hasnain S; Foroni L
Eur J Med Genet; 2016 Aug; 59(8):355-62. PubMed ID: 27263053
[TBL] [Abstract][Full Text] [Related]
4. Thalassemia intermedia in HbH-CS disease with compound heterozygosity for beta-thalassemia: challenges in hemoglobin analysis and clinical diagnosis.
Tan JA; Kok JL; Tan KL; Wee YC; George E
Genes Genet Syst; 2009 Feb; 84(1):67-71. PubMed ID: 19420802
[TBL] [Abstract][Full Text] [Related]
5. Mild beta-thalassemia intermedia caused by compound heterozygosity for (G)gamma((A)gammadeltabeta)(o)/beta-thalassemia and molecular characterization of the defect in four Chinese families.
Tan Jin Ai MA; Yap SF; Tan KL; Wong YC; Wee YC; Kok JL
Acta Haematol; 2003; 109(4):169-75. PubMed ID: 12853688
[TBL] [Abstract][Full Text] [Related]
6. Drug Repurposing: Hydroxyurea Therapy Improves the Transfusion-Free Interval in HbE/Beta-Thalassemia-Major Patients with the
Ghosh D; Panja A; Saha D; Banerjee U; Datta AK; Basu A
Genet Test Mol Biomarkers; 2021 Aug; 25(8):563-570. PubMed ID: 34406845
[No Abstract] [Full Text] [Related]
7. Genetic polymorphisms of HbE/beta thalassemia related to clinical presentation: implications for clinical diversity.
Azman NF; Abdullah WZ; Hanafi S; Diana R; Bahar R; Johan MF; Zilfalil BA; Hassan R
Ann Hematol; 2020 Apr; 99(4):729-735. PubMed ID: 32078010
[TBL] [Abstract][Full Text] [Related]
8. Hb Knossos (HBB: c.82G > T), β-globin CD 5 (-CT) (HBB: c.17_18delCT) and δ-globin CD 59 (-a) (HBD: c.179delA) mutations in a Syrian patient with β-thalassemia intermedia.
Moassas F; Nweder MS; Murad H
BMC Pediatr; 2019 Feb; 19(1):61. PubMed ID: 30777047
[TBL] [Abstract][Full Text] [Related]
9. Genotype-Phenotype Study of β-Thalassemia Patients in Sabah.
Suali L; Mohammad Salih FA; Ibrahim MY; Jeffree MSB; Thomas FM; Siew Moy F; Shook Fe Y; Suali E; Sudi S; Sunggip C
Hemoglobin; 2022 Nov; 46(6):317-324. PubMed ID: 36815306
[TBL] [Abstract][Full Text] [Related]
10. Combine-ARMS: a rapid and cost-effective protocol for molecular characterization of beta-thalassemia in Malaysia.
Tan KL; Tan JA; Wong YC; Wee YC; Thong MK; Yap SF
Genet Test; 2001; 5(1):17-22. PubMed ID: 11336396
[TBL] [Abstract][Full Text] [Related]
11. Molecular mechanisms underlying thalassemia intermedia in Iran.
Neishabury M; Azarkeivan A; Oberkanins C; Esteghamat F; Amirizadeh N; Najmabadi H
Genet Test; 2008 Dec; 12(4):549-56. PubMed ID: 18939939
[TBL] [Abstract][Full Text] [Related]
12. The molecular basis of beta-thalassemia intermedia in southern China: genotypic heterogeneity and phenotypic diversity.
Chen W; Zhang X; Shang X; Cai R; Li L; Zhou T; Sun M; Xiong F; Xu X
BMC Med Genet; 2010 Feb; 11():31. PubMed ID: 20181291
[TBL] [Abstract][Full Text] [Related]
13. Transfusion-dependent thalassemia in Northern Sarawak: a molecular study to identify different genotypes in the multi-ethnic groups and the importance of genomic sequencing in unstudied populations.
Tan JA; Chin SS; Ong GB; Mohamed Unni MN; Soosay AE; Gudum HR; Kho SL; Chua KH; Chen JJ; George E
Public Health Genomics; 2015; 18(1):60-4. PubMed ID: 25412720
[TBL] [Abstract][Full Text] [Related]
14. Genotype-Phenotype Correlation of β-Thalassemia in Malaysian Population: Toward Effective Genetic Counseling.
Abdullah UYH; Ibrahim HM; Mahmud NB; Salleh MZ; Teh LK; Noorizhab MNFB; Zilfalil BA; Jassim HM; Wilairat P; Fucharoen S
Hemoglobin; 2020 May; 44(3):184-189. PubMed ID: 32586164
[TBL] [Abstract][Full Text] [Related]
15. Molecular characterization of β-thalassemia intermedia: a report from Iran.
Arab A; Karimipoor M; Rajabi A; Hamid M; Arjmandi S; Zeinali S
Mol Biol Rep; 2011 Oct; 38(7):4321-6. PubMed ID: 21120615
[TBL] [Abstract][Full Text] [Related]
16. Association between clinical expression and molecular heterogeneity in β-thalassemia Tunisian patients.
Jouini L; Sahli CA; Laaouini N; Ouali F; Ben Youssef I; Dakhlaoui B; Othmeni R; Ouennich F; Hadj Fredj S; Siala H; Becher M; Toumi NE; Fattoum S; Hafsia R; Bibi A; Messaoud T
Mol Biol Rep; 2013 Nov; 40(11):6205-12. PubMed ID: 24065537
[TBL] [Abstract][Full Text] [Related]
17. Molecular basis of transfusion dependent beta-thalassemia major patients in Sabah.
Teh LK; George E; Lai MI; Tan JA; Wong L; Ismail P
J Hum Genet; 2014 Mar; 59(3):119-23. PubMed ID: 24369358
[TBL] [Abstract][Full Text] [Related]
18. Thalassemia in Malaysia.
Alwi ZB; Syed-Hassan SR
Hemoglobin; 2022 Jan; 46(1):45-52. PubMed ID: 35950577
[TBL] [Abstract][Full Text] [Related]
19. A novel 223 kb deletion in the beta-globin gene cluster was identified in a Chinese thalassemia major patient.
Zhu F; Wei X; Cai D; Pang D; Zhong J; Liang M; Zuo Y; Xu X; Shang X
Int J Lab Hematol; 2019 Aug; 41(4):456-460. PubMed ID: 30945812
[TBL] [Abstract][Full Text] [Related]
20. The associations of SEA-alpha thalassemia 1, XmnI-Ggamma polymorphism and beta-globin gene mutations with the clinical severity of beta-thalassemia syndrome in northern Thailand.
Tatu T; Sritong W; Sa-Nguansermsri T
J Med Assoc Thai; 2014 Mar; 97(3):300-7. PubMed ID: 25123009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
